DAWN NASDAQ
Day One Biopharmaceuticals, Inc.
1W: +0.3%
1M: +0.8%
3M: +80.2%
YTD: +143.3%
1Y: +189.4%
3Y: +69.9%
$21.53
Last traded 2026-04-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$158M
Revenue
+20.6% YoY
$-107M
Net Income
-12.4% YoY
$-108M
Free Cash Flow
+29.4% YoY
88.7%
Gross Margin
-51.1%
Op. Margin
-39.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-22.7%
ROA-19.7%
ROIC-3551.1%
Valuation
P/E-31.2
P/B5.0
EV/EBITDA-5.0
Leverage
Debt/Equity0.01
Current Ratio8.02
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z7.45
Beneish M-1.56